Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2011-01-04
Original SEC Filing: Click here

---

Webplus: SVA/20110104/6-K/2_EX-99.1/000.htm SEC Original: a11-1201_1ex99d1.htm
Sinovac Receives SFDA Approval to Commence Clinical Trials For Inactivated Enterovirus Type 71 Vaccine BEIJING, December 28, 2010 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that it received approval from the China State Food and Drug Administration (SFDA) to commence clinical trials for its proprietary inactivated EV71 vaccine against Hand,

---

---

Webplus: SVA/20110104/6-K/3_EX-99.2/000.htm SEC Original: a11-1201_1ex99d2.htm
BEIJING, December 31, 2010 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its common shares will be listed on the NASDAQ Global Select Market effective January 3, 2011. The Company received notification from the NASDAQ Stock Market dated December 7, 2010 that as part of the exchange’s annual review of Global

---

---

Webplus: SVA/20110104/6-K/1/000.htm SEC Original: a11-1201_16k.htm
SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2011-01-04CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085